• Everyday Alpha
  • Posts
  • The E-Commerce Pullback Where the Fear Is Already Priced In

The E-Commerce Pullback Where the Fear Is Already Priced In

This summer's most beaten-down retail name might be setting up its comeback swing.

This company is down more than 45% from its 52-week high, with 27 million shares sold short and earnings five weeks out.

America’s AI Buildout (Sponsored)

Taiwan Semiconductor just posted strong earnings and raised its full-year growth outlook above 40%.

But the bigger story may be its expanding U.S. investment. The chipmaker is reportedly adding another $100 billion to the $165 billion it already committed to American manufacturing.

That is $265 billion moving into U.S. chip infrastructure as the AI race accelerates.

One analyst believes this spending points to a much larger government-backed AI project now taking shape, and he has identified one little-known company that could be positioned directly in its path.

Chewy, Inc.

August 7 – Pre‑market
Ticker: CHWY | Sector: Consumer Cyclical | Market Cap: ~$9.63B

30‑Second Take

Why now? Chewy has been the piñata of consumer discretionary this summer. You've watched prices take a beating, sliding from a 52-week high of $43.50 down to $23.43. Amazon's push into pet, softer discretionary spend, and a wider sell-off in anything touching consumer e-commerce have all played a part.

And then the selling got indiscriminate.

Short interest sits at 27.33M shares, about 6.7% of the shares outstanding and up from 25.31M the prior month. Forward earnings are being valued at 14.6x against a trailing 39x.

That is a crowded short base sitting in front of a September earnings date, in a category that does not stop spending. You want to be early to that, not late.

Trade Setup

Time frame: Swing (2 to 6 weeks)
Edge type: Contrarian rebound into a washed-out setup

Learn More (Sponsored)

Louis Navellier says his $9 million Stock Grader system is flashing its highest rating on one AI stock for 2026.

This company recently reported record annual revenue of $113.5 billion, earned an A-rating in his system, and is tied to a major AI expansion linked to Elon Musk’s “Project Apex.”

Navellier says this is the same system that helped him spot Nvidia long before its historic run.

Now, he is revealing the name, ticker, and full analysis of his #1 AI stock pick for 2026, completely free.

The New York Stock Exchange is synonymous with American finance — but it wasn't the first stock exchange in the U.S. Which was?

Login or Subscribe to participate in polls.

Snapshot Table

Metric

Value

Current Stance

Price

$23.53

Below average

52‑week range

$17.40 - $43.50

Below average

Market Cap

$9.63B

Mid-cap, plenty of liquidity

Beta

1.42

Higher beta, moves faster than the market

P/E Ratio

39.13 trailing / 14.64 forward

Priced for a recovery in earnings

Avg Daily Volume

7.60M shares (20-day)

Deep liquidity, easy in and out

Next Catalyst

Q2 earnings, September 9, 2026

The event that confirms or kills the setup

Chart

1-Month Synopsis: CHWY has been under heavy pressure over the past month, giving back a chunk of value as sentiment around consumer discretionary and Amazon's pet push weighed on the shares.

The stock is trading around $23.40, well off the $43.50 high but still comfortably above its 52-week low of $17.40. Which tells you a lot about the setup. The fear is priced in, sellers have been active, and any positive surprise from here creates a violent snapback.

That's the asymmetry.

Bull Case 

Core thesis: Chewy runs the largest online pet retailer in the US, and pet spending is one of the stickiest categories in all of consumer discretionary.

People don't cut back on their dog's food before their own coffee.

Auto-ship, Chewy's subscription backbone, still delivers the majority of net sales with retention rates the physical retailers can only dream about.

Catalysts to watch: the stock has round-tripped a full year of gains while revenue kept growing, and the forward multiple has compressed to 14.6x. That is the gap you are being paid to close.

Nothing here needs a heroic assumption. It needs the business to keep doing what it has been doing while sentiment normalizes.

A few things stack up from here.

Q2 earnings land on September 9, and expectations have been crushed, so the bar you need it to clear is on the floor. Chewy Vet Care clinics are ramping, adding the higher-margin adjacency the story has been missing. The company has been buying back stock, and at $23 the math works better for you than it did at $40. Sentiment is washed out, so surprise risk skews in your favor.

Valuation upside: The pet TAM in the US is still growing mid-single digits, and Chewy owns the online lane. Strip out the noise and you're paying a mid-cap price for a category leader with a subscription revenue base.

That gap is the opportunity.

Bear Case 

You need to know what could blow this up.

Amazon's push into pet is real, and Chewy has been giving back share in some categories. That's not going away. If Amazon Prime Pet Pharmacy scales aggressively into 2026, the margin compression story gets uglier before it gets better.

The consumer piece is a genuine risk too. Discretionary categories are still under pressure, and while pet is stickier than most, the premiumization trend that drove Chewy's margins higher is reversing. Your neighbors are trading down to cheaper food brands. That hits gross margins directly.

Then there's the earnings binary. Q2 results are the catalyst that either confirms the thesis or blows it up. Guide Q3 conservatively and you'll see another leg down before the rebound.

Size accordingly. This is a swing trade, not a lifetime hold.

One more thing you should know: CEO Sumit Singh disposed of 81,841 shares between July 31 and August 3, roughly $1.9M worth, per his Form 4. Planned or not, that is not the signal a bull wants to see going into a print.

One last risk to keep on your radar. A heavy short base cuts both ways. It can fuel a violent snapback, and it can also mean the people who study this company most closely think the margin story gets worse first. Respect the other side of the trade.

Quick Checklist 

✅ Thesis still valid after today's close
✅ Volume confirms bounce above the $24.50 level
✅ Q2 earnings date confirmed (September 9, 2026) and short interest still elevated

That’s all for today’s Everyday Alpha. We’ll have a new pick for you every morning before the market opens, so stay tuned!

Best Regards,
—Noah Zelvis
Everyday Alpha